198 related articles for article (PubMed ID: 17203972)
1. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
[TBL] [Abstract][Full Text] [Related]
2. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
3. Generation of mice with conditionally activated transforming growth factor beta signaling through the TbetaRI/ALK5 receptor.
Bartholin L; Cyprian FS; Vincent D; Garcia CN; Martel S; Horvat B; Berthet C; Goddard-Léon S; Treilleux I; Rimokh R; Marie JC
Genesis; 2008 Dec; 46(12):724-31. PubMed ID: 18821589
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
Ge R; Rajeev V; Subramanian G; Reiss KA; Liu D; Higgins L; Joly A; Dugar S; Chakravarty J; Henson M; McEnroe G; Schreiner G; Reiss M
Biochem Pharmacol; 2004 Jul; 68(1):41-50. PubMed ID: 15183116
[TBL] [Abstract][Full Text] [Related]
5. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
McLean S; Di Guglielmo GM
Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteome profiling of transforming growth factor-beta (TGFbeta) signaling: nonglycosylated cell death-inducing DFF-like effector A inhibits TGFbeta1-dependent apoptosis.
Iwahana H; Yakymovych I; Dubrovska A; Hellman U; Souchelnytskyi S
Proteomics; 2006 Dec; 6(23):6168-80. PubMed ID: 17080483
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
8. Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5).
Singh J; Ling LE; Sawyer JS; Lee WC; Zhang F; Yingling JM
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):437-45. PubMed ID: 15338953
[TBL] [Abstract][Full Text] [Related]
9. Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells.
Koli KM; Arteaga CL
Cancer Res; 1997 Mar; 57(5):970-7. PubMed ID: 9041203
[TBL] [Abstract][Full Text] [Related]
10. Single-molecule force spectroscopy study of interaction between transforming growth factor beta1 and its receptor in living cells.
Yu J; Wang Q; Shi X; Ma X; Yang H; Chen YG; Fang X
J Phys Chem B; 2007 Dec; 111(48):13619-25. PubMed ID: 17997544
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.
Adnane J; Bizouarn FA; Chen Z; Ohkanda J; Hamilton AD; Munoz-Antonia T; Sebti SM
Oncogene; 2000 Nov; 19(48):5525-33. PubMed ID: 11114730
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells.
Chen KL; Liu WH; Yang YY; Leu SJ; Shih NY
BMC Mol Biol; 2007 Aug; 8():72. PubMed ID: 17705854
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
14. Altered primordial germ cell migration in the absence of transforming growth factor beta signaling via ALK5.
Chuva de Sousa Lopes SM; van den Driesche S; Carvalho RL; Larsson J; Eggen B; Surani MA; Mummery CL
Dev Biol; 2005 Aug; 284(1):194-203. PubMed ID: 15993878
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.
Sato S; Futakuchi M; Ogawa K; Asamoto M; Nakao K; Asai K; Shirai T
Cancer Sci; 2008 Feb; 99(2):316-23. PubMed ID: 18271931
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
17. Dynamic interaction of cAMP with the Rap guanine-nucleotide exchange factor Epac1.
Kraemer A; Rehmann HR; Cool RH; Theiss C; de Rooij J; Bos JL; Wittinghofer A
J Mol Biol; 2001 Mar; 306(5):1167-77. PubMed ID: 11237625
[TBL] [Abstract][Full Text] [Related]
18. Binding of coronin 1B to TβRI negatively regulates the TGFβ1 signaling pathway.
Kim GY; Lim HJ; Park HY
Biochem Biophys Res Commun; 2017 Aug; 490(2):574-579. PubMed ID: 28625921
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
20. Vectorial TGFbeta signaling in polarized intestinal epithelial cells.
Yakovich AJ; Huang Q; Du J; Jiang B; Barnard JA
J Cell Physiol; 2010 Aug; 224(2):398-404. PubMed ID: 20432436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
